Search bioRxiv⌕ Search

Biology subjects

Lee, Y. Z.

Publications and source records attributed to Lee, Y. Z..

4 recordsLinked to original sources

Geometric coordination of endothelial invasion and vascular patterning during epithelial morphogenesis

As organs grow and remodel in three dimensions, developing vascular networks extend through the tissue while maintaining spatial coordination and establishing connections between distant sprouts. How local endothelial behavior generates vascular patterns within such deforming environments remains poorly understood. Here, using the developing mouse epididymis, we combine two-photon live microscopy, pharmacological perturbations, and mathematical modeling to investigate angiogenesis alongside epithelial tubule folding. Endothelial cells invade the organ interior while maintaining proximity to the deforming tubule. Live imaging reveals dynamic protrusions directed toward the epithelium and a characteristic sequence in which endothelial fronts approach the tubule, stop, and maintain their separation despite continued folding. ERK activity promotes endothelial extension and declines during the transition to distance maintenance. From these observations, we derive a minimal follow-and-stop rule that captures endothelial positioning relative to the changing epithelium. Extending this model to three dimensions reveals how epithelial folding can bring otherwise distant endothelial fronts together, creating opportunities for vascular connection. Explants exhibiting greater three-dimensional folding also show a higher observed frequency of endothelial connections. Our findings support a geometric framework in which local endothelial dynamics and tissue-scale deformation can jointly contribute to vascular patterning during organ morphogenesis.

developmental biology↗

Toward the Clinical Translation of Safe Intravenous Long Circulating Iodinated Lipid Nanoemulsion Contrast Agents for CT Imaging

Current clinical small molecule x-ray CT agents are effective but pose risks such as nephrotoxicity, short blood circulation time, limiting scan durations, potential thyroid impact, and immune responses. These challenges drive the development of kidney-safe x-ray nanoparticle (NP)-based contrast agents (CAs), though translation to clinical practice is hindered by chemical complexities and potential toxicity. We have engineered an intravenous, injectable, and safe blood pool NP-based CT CAs at a clinical-equivalent dose of [~]300 mgI/kg ([~]2 mL/kg), ideal for vascular and hepatic imaging which are limited by clinical agents. Our iodinated lipid nanodroplet emulsions (ILNEs) contrast agent offers high x-ray attenuation thus improved contrast enhancement, extended stability, and exceptional batch-to-batch consistency. It also boasts a straightforward and scalable manufacturing process with minimal protein interaction, prolonged blood residency ([~]4h), and hepatic clearance within 3 days, avoiding nephrotoxicity. Studies in vitro, in mice, and 16.6kg porcine animal model studies confirm its safety, cytocompatibility, and absence of tissue damage. Blood, and thyroid-stimulating hormone (TSH) analyses, and kidney and liver function tests, also support further toxicity evaluations for clinical translation.

bioengineering↗

A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies

COVID-19 survivors develop post-acute sequelae of SARS-CoV-2 (PASC), but the mechanistic basis of PASC-associated lung abnormalities suffers from a lack of longitudinal samples. Mouse-adapted SARS-CoV-2 MA10 produces an acute respiratory distress syndrome (ARDS) in mice similar to humans. To investigate PASC pathogenesis, studies of MA10-infected mice were extended from acute disease through clinical recovery. At 15-120 days post-virus clearance, histologic evaluation identified subpleural lesions containing collagen, proliferative fibroblasts, and chronic inflammation with tertiary lymphoid structures. Longitudinal spatial transcriptional profiling identified global reparative and fibrotic pathways dysregulated in diseased regions, similar to human COVID-19. Populations of alveolar intermediate cells, coupled with focal upregulation of pro-fibrotic markers, were identified in persistently diseased regions. Early intervention with antiviral EIDD-2801 reduced chronic disease, and early anti-fibrotic agent (nintedanib) intervention modified early disease severity. This murine model provides opportunities to identify pathways associated with persistent SARS-CoV-2 pulmonary disease and test countermeasures to ameliorate PASC.

microbiology↗

Altered hypothalamic diffusivity in Parkinsonian autonomic dysfunction

The pathophysiological basis of autonomic symptoms in Parkinsons disease remains incompletely understood. The hypothalamus plays a key regulatory role in autonomic function and has been shown to be affected in Parkinsons disease. Here, using diffusion magnetic resonance imaging, we investigated whether microstructural properties of the hypothalamus differ in Parkinsons disease patients with high compared to low autonomic symptom burden.\n\nParkinsons disease patients with low (n=25) and high (n=25) autonomic symptom burden were identified from a larger pool, based on scores from a questionnaire assessing autonomic symptoms in Parkinsons disease (SCOPA-AUT). In each patient, we first segmented the hypothalamus manually, based on anatomical landmarks. Diffusivity measures were then extracted from the hypothalamus. Diffusivity measures calculated in the brainstem and the putamen were used to assess the specificity of the results.\n\nRelative to patients with low autonomic symptom burden, patients with high burden showed increased mean, axial, and radial diffusivity in the hypothalamus. In contrast, we did not find significant group differences in any of these measures extracted from the brainstem or the putamen.\n\nThese results reveal consistent differences in the microstructural properties of the hypothalamus between patients with low and high autonomic symptom burden. Hypothalamic diffusivity properties can thus potentially be used as an imaging marker to assist in the identification of therapeutic targets for autonomic dysfunction in Parkinsons disease.

neuroscience↗